Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Change in Accured Expenses (2023 - 2025)

Ardent Health (ARDT) has 3 years of Change in Accured Expenses data on record, last reported at $16.4 million in Q3 2025.

  • For Q3 2025, Change in Accured Expenses rose 114.6% year-over-year to $16.4 million; the TTM value through Sep 2025 reached $8.5 million, up 107.12%, while the annual FY2024 figure was -$103.9 million, 553.44% down from the prior year.
  • Change in Accured Expenses reached $16.4 million in Q3 2025 per ARDT's latest filing, up from $10.6 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $36.0 million in Q3 2023 and bottomed at -$112.6 million in Q3 2024.
  • Average Change in Accured Expenses over 3 years is -$8.3 million, with a median of $12.9 million recorded in 2023.
  • The widest YoY moves for Change in Accured Expenses: up 118.23% in 2024, down 412.76% in 2024.
  • A 3-year view of Change in Accured Expenses shows it stood at $12.9 million in 2023, then surged by 118.23% to $28.2 million in 2024, then crashed by 41.62% to $16.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $16.4 million in Q3 2025, $10.6 million in Q2 2025, and -$46.7 million in Q1 2025.